Novel compound heterozygous mutations of CLDN16 in a patient with familial hypomagnesemia with hypercalciuria and nephrocalcinosis
Abstract Background Familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC) is an autosomal recessive tubulopathy characterized by excessive urinary wasting of magnesium and calcium, bilateral nephrocalcinosis, and progressive chronic renal failure in childhood or adolescence. FHHNC...
Main Authors: | Alejandro García‐Castaño, Ana Perdomo‐Ramirez, Mònica Vall‐Palomar, Elena Ramos‐Trujillo, Leire Madariaga, Gema Ariceta, Felix Claverie‐Martin |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-11-01
|
Series: | Molecular Genetics & Genomic Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/mgg3.1475 |
Similar Items
-
Novel Variant in CLDN16: A Further Step in the Diagnosis of Familial Hypomagnesemia with Hypercalciuria and Nephrocalcinosis—A Case Report
by: Gopal Narang, et al.
Published: (2021-06-01) -
Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis: The first four patients in Serbia
by: Peco-Antić Amira, et al.
Published: (2010-01-01) -
Association of TRPV6, CLDN16, and SLC26A6 gene polymorphisms with the risk of nephrolithiasis and nephrocalcinosis in children with hypercalciuria
by: S. V. Maltsev, et al.
Published: (2016-03-01) -
Urinary Acidification Does Not Explain the Absence of Nephrocalcinosis in a Mouse Model of Familial Hypomagnesaemia with Hypercalciuria and Nephrocalcinosis (FHHNC)
by: Amr Al-Shebel, et al.
Published: (2024-02-01) -
Exonic CLDN16 mutations associated with familial hypomagnesemia with hypercalciuria and nephrocalcinosis can induce deleterious mRNA alterations
by: Ana Perdomo-Ramirez, et al.
Published: (2019-01-01)